| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 130.70B | 133.45B | 142.38B | 155.50B | 142.61B | 111.24B |
| Gross Profit | 19.66B | 27.44B | 30.54B | 37.23B | 31.19B | 28.29B |
| EBITDA | 18.10B | 18.56B | 20.24B | 27.47B | 22.55B | 19.94B |
| Net Income | 6.82B | 7.29B | 7.29B | 11.29B | 17.94B | 12.38B |
Balance Sheet | ||||||
| Total Assets | 270.62B | 278.35B | 267.73B | 250.89B | 246.93B | 229.53B |
| Cash, Cash Equivalents and Short-Term Investments | 19.01B | 18.85B | 21.85B | 17.33B | 22.03B | 21.81B |
| Total Debt | 112.18B | 106.30B | 85.50B | 71.55B | 71.56B | 83.73B |
| Total Liabilities | 171.07B | 180.45B | 172.73B | 157.97B | 155.64B | 154.40B |
| Stockholders Equity | 97.27B | 95.70B | 92.31B | 89.60B | 87.13B | 74.37B |
Cash Flow | ||||||
| Free Cash Flow | -4.23B | -2.98B | -4.64B | 6.47B | 14.47B | 9.28B |
| Operating Cash Flow | 5.61B | 7.98B | 7.57B | 17.36B | 23.52B | 15.90B |
| Investing Cash Flow | -9.38B | -9.95B | -11.37B | -9.55B | -4.77B | -6.39B |
| Financing Cash Flow | 3.13B | 1.62B | 5.77B | -6.67B | -17.98B | -6.74B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
72 Outperform | €9.69B | 2.31 | 7.44% | 4.81% | -13.16% | ― | |
61 Neutral | €44.00B | 7.28 | 7.21% | 4.72% | -6.32% | 6.34% | |
60 Neutral | €48.12B | 8.80 | 5.28% | 7.25% | -8.64% | -43.01% | |
55 Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% | |
54 Neutral | €7.94B | 62.30 | 3.07% | 1.17% | -2.77% | -69.52% | |
54 Neutral | €8.82B | 27.80 | 7.96% | 3.15% | 16.50% | 57.62% | |
52 Neutral | €44.59B | 7.50 | 3.77% | 6.13% | -2.06% | -33.95% |